Clinical Trials Logo

Induced Vaginal Delivery clinical trials

View clinical trials related to Induced Vaginal Delivery.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06339528 Completed - Clinical trials for Induced Vaginal Delivery

Potential of Vojta's Reflex Locomotion as a Pre/Induction Method for Uterine Activity: a Pilot Study

Start date: June 23, 2021
Phase: N/A
Study type: Interventional

The Vojta's method is neurophysiological rehabilitation method used to support and induce reflex responses of locomotor and vegetative system. It uses involuntary motor reaction of the body during pressure stimulation of so-called trigger zones. Pregnancy is currently considered a contraindication for using Vojta's therapy to potential risks of inducing regular uterine activity and risk of delivery. The aim of the study is to evaluate changes in uterine activity and also explore the possibility of using this method as a new approach for pre/induction of delivery.

NCT ID: NCT05424445 Completed - Clinical trials for Induced Vaginal Delivery

MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor

Start date: January 21, 2022
Phase: Phase 3
Study type: Interventional

The aim of the study is to evaluate efficacy of the cervical ripening of misoprostol administration in oral tablet, Angusta® compared with the off-label solution of misoprostol (Cytotec®) for induction of labor (IOL). Since there is a large cost difference between the preparations (Angusta® is 43 times more expensive than Cytotec®) it is, from a socio-economic perspective, of great interest to evaluate if Angusta can be replaced by Cytotec.

NCT ID: NCT05097326 Completed - Clinical trials for Induced Vaginal Delivery

Mifepristone for Labor Induction

MiLI
Start date: June 27, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to explore mifepristone as an option for induction of labor at term by evaluating the efficacy of mifepristone use for cervical preparation. Since the Labor Induction versus Expectant Management in Low-Risk Nulliparous Women (ARRIVE) trial supporting that elective induction after 39 weeks decreases cesarean sections and morbidity, rates of elective term inductions are increasing. At Lucile Packard Children's Hospital at Stanford University specifically, approximately 40% of spontaneous vaginal deliveries follow induction of labor, with an average induction time of 20 hours. Previous studies have established the maternal and neonatal safety of mifepristone in term inductions, however, this study will assess the difference in overall time from induction to complete cervical dilation, delivery, and the total time on Labor and Delivery.

NCT ID: NCT03629548 Completed - Clinical trials for Induced Vaginal Delivery

Comparing Foley Catheter Balloon With Early Amniotomy for Induction of Labor at Term

Start date: August 15, 2018
Phase: N/A
Study type: Interventional

This study evaluates the intervention for induction of labor with low bishop scores . One group will be induced by transcervical Foley catheter balloon and vaginal PGE2 and other group will be induced by early amniotomy and PGE2 vaginal ovule for induction of labor at term.